Mike Matson Analyst PerformanceSenior Analyst at Needham & Company LLCMike Matson is a stock analyst at Needham & Company LLC in the healthcare sector, covering 33 publicly traded companies. Over the past year, Mike Matson has issued 88 stock ratings, including buy and hold recommendations. While full access to Mike Matson's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Mike Matson's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings405 Last 12 YearsBuy Recommendations75.68% 305 Buy RatingsCompanies Covered33 Unique Companies Ratings Distribution403RatingsDistribution of strong buy, buy, hold, and sell ratings by Mike Matson.RatingPercentageCount Strong Buy4.2%17 ratings Buy71.5%288 ratings Hold23.6%95 ratings Sell0.7%3 ratingsOut of 403 total stock ratings issued by Mike Matson at Needham & Company LLC, the majority (71.5%) have been Buy recommendations, followed by 23.6% Hold, 4.2% Strong Buy, and 0.7% Sell.Best & Worst CallsBest Call0000.0%AMDANov 2015Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%NEONov 2021Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ60.6% of companies on NASDAQ20 companiesNYSE39.4% of companies on NYSE13 companiesMike Matson, an analyst at Needham & Company LLC, currently covers 33 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare33 companies100.0%Mike Matson of Needham & Company LLC specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageHEALTHCARE EQUIPMENT & SUPPLIES27 companies81.8%BIOTECHNOLOGY4 companies12.1%HEALTHCARE PROVIDERS & SERVICES1 company3.0%LIFE SCIENCES TOOLS & SERVICES1 company3.0% About Mike MatsonMike Matson joined Needham & Company in 2013 covering Medical Technologies & Diagnostics. Prior to joining Needham, Mike spent nine years covering the Medical Supplies and Devices industry for Mizuho Securities and Wells Fargo Securities. He previously worked in the medical device industry for Stryker’s Orthopaedics and Endoscopy divisions in marketing and product development. Mike has received multiple awards for stock picking and earnings estimate accuracy. He was ranked first for stock picking in the Health Care Equipment & Supplies sector in the 2017 Thomson Reuters Analyst Awards. He was also ranked tenth in the TipRanks Top Ten Analysts of 2016 (across all sectors), third for earnings estimate accuracy in the Health Care Equipment & Supplies sector in the 2014 Thomson Reuters Analyst Awards, first for earnings estimate accuracy in the Health Care Equipment & Supplies sector in the 2013 Thomson Reuters Analyst Awards, second for stock picking in the Health Care Equipment & Supplies sector in the 2008 Thomson Reuters Analyst Awards, and fourth in the medical device sector for stock picking in the 2007 Wall Street Journal Best on the Street. Mike has a BS in Mechanical Engineering from North Carolina State University with a minor in Economics and a MBA from Duke University’s Fuqua School of Business with a concentration in Health Sector Management. Mike holds a medical device patent (U.S. patent 6,919,914).Follow on LinkedIn Mike Matson's Ratings History at Needham & Company LLC Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsVCYTVeracyte9/15/2026Reiterated Rating$41.21Buy$0.0000.00% ROITMDXTransMedics Group9/11/2026Reiterated Rating$85.04Buy$0.0000.00% ROIATRCAtriCure9/2/2026Boost Price Target$48.92$64.00Buy$0.0000.00% ROIMDTMedtronic8/27/2026Boost Price Target$92.16$114.00Buy$0.0000.00% ROITFXTeleflex8/25/2026Boost Price Target$138.31$170.00Buy$0.0000.00% ROIIMDXOncocyte8/18/2026Reiterated Rating$4.27$9.00Buy$0.0000.00% ROIPLSEPulse Biosciences8/17/2026Initiated Coverage$44.54$58.00Buy$0.0000.00% ROIICUIICU Medical8/7/2026Boost Price Target$166.37$187.00Buy$0.0000.00% ROIESTAEstablishment Labs8/6/2026Boost Price Target$79.05$95.00Buy$0.0000.00% ROIKIDSOrthoPediatrics8/5/2026Boost Price Target$20.88$35.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. LIVNLivaNova8/5/2026Boost Price Target$75.34$93.00Buy$0.0000.00% ROITMDXTransMedics Group8/3/2026Lower Price Target$76.51$106.00Buy$0.0000.00% ROIVCYTVeracyte7/31/2026Boost Price Target$59.78$69.00Buy$0.0000.00% ROITFXTeleflex7/31/2026Boost Price Target$132.34$159.00Buy$0.0000.00% ROIMMSIMerit Medical Systems7/31/2026Boost Price Target$83.35$101.00Buy$0.0000.00% ROINEONeoGenomics7/29/2026Boost Price Target$13.40$19.00Buy$0.0000.00% ROIAORTArtivion7/20/2026Reiterated Rating$25.07$44.00Buy$0.0000.00% ROIPSNLPersonalis7/20/2026Downgrade$13.21Hold$0.0000.00% ROIPSNLPersonalis7/17/2026Boost Price Target$15.58$17.00Buy$0.0000.00% ROIBSXBoston Scientific7/8/2026Lower Price Target$45.30$57.00Buy$0.0000.00% ROIMDTMedtronic6/17/2026Reiterated Rating$81.36$101.00Buy$0.0000.00% ROIMDTMedtronic6/3/2026Lower Price Target$77.72$101.00Buy$0.0000.00% ROIVCYTVeracyte6/1/2026Boost Price Target$48.79$57.00Buy$0.0000.00% ROIVCYTVeracyte5/28/2026Reiterated Rating$44.49$48.00Buy$0.0000.00% ROIICUIICU Medical5/27/2026Upgrade$134.97$165.00Buy$0.0000.00% ROIBSXBoston Scientific5/18/2026Reiterated Rating$55.35$77.00Buy$0.0000.00% ROIAORTArtivion5/8/2026Lower Price Target$35.38$44.00Buy$0.0000.00% ROITMDXTransMedics Group5/6/2026Lower Price Target$94.93$142.00Buy$0.0000.00% ROISYKStryker5/1/2026Lower Price Target$314.64$418.00Buy$0.0000.00% ROIMMSIMerit Medical Systems5/1/2026Lower Price Target$68.18$90.00Buy$0.0000.00% ROIBSXBoston Scientific4/23/2026Lower Price Target$64.95$77.00Buy$0.0000.00% ROIAORTArtivion4/20/2026Reiterated Rating$37.79Buy$0.0000.00% ROIAORTArtivion4/7/2026Reiterated Rating$35.00$58.00Buy$0.0000.00% ROIVCYTVeracyte4/1/2026Reiterated Rating$32.21$48.00Buy$0.0000.00% ROIMMSIMerit Medical Systems4/1/2026Reiterated Rating$68.23$101.00Buy$0.0000.00% ROIBSXBoston Scientific3/30/2026Reiterated Rating$69.21$97.00Buy$0.0000.00% ROIMDTMedtronic3/26/2026Reiterated Rating$87.84$120.00Buy$0.0000.00% ROILUCDLucid Diagnostics3/26/2026Reiterated Rating$1.18$3.00Buy$0.0000.00% ROIBSXBoston Scientific3/20/2026Reiterated Rating$70.04$97.00Buy$0.0000.00% ROIMDTMedtronic3/10/2026Reiterated Rating$90.21$120.00Buy$0.0000.00% ROIA “bloodbath” Is Coming (Ad)Reports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the country entirely - as concerns grow about the next phase of the AI market. One AI insider says investors should reassess their positions before September 30, pointing to a critical shift ahead for tech and AI-related stocks.Read the full warning about the AI market's next phase nowKIDSOrthoPediatrics2/27/2026Boost Price Target$17.79$30.00Buy$0.0000.00% ROIPSNLPersonalis2/27/2026Boost Price Target$9.03$12.00Buy$0.0000.00% ROIENOVEnovis2/26/2026Boost Price Target$25.39$52.00Buy$0.0000.00% ROITFXTeleflex2/26/2026Boost Price Target$119.19$147.00Buy$0.0000.00% ROIVCYTVeracyte2/26/2026Boost Price Target$35.72$48.00Buy$0.0000.00% ROIMMSIMerit Medical Systems2/25/2026Lower Price Target$82.43$101.00Buy$0.0000.00% ROITMDXTransMedics Group2/25/2026Boost Price Target$137.78$174.00Buy$0.0000.00% ROILIVNLivaNova2/25/2026Boost Price Target$69.98$81.00Buy$0.0000.00% ROIESTAEstablishment Labs2/24/2026Boost Price Target$76.35$86.00Buy$0.0000.00% ROIMDTMedtronic2/17/2026Lower Price Target$96.33$120.00Buy$0.0000.00% ROINEONeoGenomics2/17/2026Boost Price Target$11.44$15.00Buy$0.0000.00% ROIATRCAtriCure2/12/2026Reiterated Rating$32.90$45.00Buy$0.0000.00% ROIZBHZimmer Biomet2/10/2026Reiterated Rating$92.60Hold$0.0000.00% ROIMDTMedtronic2/9/2026Upgrade$102.89$121.00Buy$0.0000.00% ROIBSXBoston Scientific2/5/2026Lower Price Target$75.50$97.00Buy$0.0000.00% ROIAORTArtivion2/2/2026Reiterated Rating$41.12$58.00Buy$0.0000.00% ROISYKStryker1/30/2026Boost Price Target$354.39$454.00Buy$0.0000.00% ROICNMDCONMED1/29/2026Reiterated Rating$38.59Hold$0.0000.00% ROITFXTeleflex1/27/2026Upgrade$104.13$138.00Buy$0.0000.00% ROIPENPenumbra1/16/2026Downgrade$350.53Hold$0.0000.00% ROIBSXBoston Scientific1/15/2026Reiterated Rating$90.00Buy$0.0000.00% ROINEONeoGenomics1/12/2026Reiterated Rating$12.57$14.00Buy$0.0000.00% ROIESTAEstablishment Labs1/12/2026Reiterated Rating$66.13$84.00Buy$0.0000.00% ROIMMSIMerit Medical Systems1/9/2026Reiterated Rating$93.18$108.00Buy$0.0000.00% ROIPENPenumbra12/17/2025Boost Price Target$308.27$388.00Buy$0.0000.00% ROIHAEHaemonetics12/15/2025Downgrade$83.46Hold$0.0000.00% ROIESTAEstablishment Labs12/10/2025Boost Price Target$71.01$84.00Buy$0.0000.00% ROITMDXTransMedics Group12/8/2025Boost Price Target$136.51$166.00Buy$0.0000.00% ROISYKStryker11/14/2025Reiterated Rating$372.93$448.00Buy$0.0000.00% ROILUCDLucid Diagnostics11/13/2025Reiterated Rating$1.11$3.00Buy$0.0000.00% ROIHAEHaemonetics11/7/2025Boost Price Target$67.66$78.00Buy$0.0000.00% ROIAORTArtivion11/7/2025Boost Price Target$47.54$58.00Buy$0.0000.00% ROIESTAEstablishment Labs11/6/2025Boost Price Target$60.51$70.00Buy$0.0000.00% ROIPSNLPersonalis11/5/2025Boost Price Target$8.73$10.00Buy$0.0000.00% ROIVCYTVeracyte11/5/2025Boost Price Target$36.12$44.00Buy$0.0000.00% ROIHOLXHologic11/4/2025Reiterated Rating$74.06Hold$0.0000.00% ROIMMSIMerit Medical Systems10/31/2025Reiterated Rating$83.04$108.00Buy$0.0000.00% ROITMDXTransMedics Group10/30/2025Reiterated Rating$134.32Buy$0.0000.00% ROIKIDSOrthoPediatrics10/29/2025Lower Price Target$16.91$26.00Buy$0.0000.00% ROIPENPenumbra10/27/2025Reiterated Rating$253.61$326.00Buy$0.0000.00% ROITMDXTransMedics Group10/23/2025Upgrade$119.54$148.00Buy$0.0000.00% ROIHOLXHologic10/21/2025Reiterated Rating$74.17Hold$0.0000.00% ROIBSXBoston Scientific10/17/2025Reiterated Rating$98.54$121.00Buy$0.0000.00% ROIINMDInMode10/10/2025Reiterated Rating$15.89Hold$0.0000.00% ROIPENPenumbra10/8/2025Set Price Target$249.05$326.00Buy$0.0000.00% ROIPENPenumbra10/8/2025Upgrade$258.92$326.00Buy$0.0000.00% ROIBSXBoston Scientific10/1/2025Reiterated Rating$97.55$121.00Buy$0.0000.00% ROIBSXBoston Scientific9/19/2025Reiterated Rating$98.29$121.00Buy$0.0000.00% ROIBSXBoston Scientific9/11/2025Reiterated Rating$105.32$121.00Buy$00.0000.00% ROILIVNLivaNova9/3/2025Reiterated Rating$56.92$64.00Buy$00.0000.00% ROI$20,000 gold before year end? (Ad)President Trump reposted a warning from precious metals expert Jim Rickards, tying the November midterms and America's $40 trillion national debt to a potential surge in gold prices, with some forecasts pointing to $10,000 or even $20,000 gold. Dr. David Eifrig, a 40-year market veteran and former Goldman Sachs Vice President, says an unusual plan involving Trump and two other top officials could fuel the biggest gold bull run in decades. Eifrig has shared his top gold pick tied to this developing story.Read the full gold report and see Eifrig's top pick nowNEONeoGenomics8/29/2025Boost Price Target$8.87$14.00Buy$00.0000.00% ROITMDXTransMedics Group8/25/2025Reiterated Rating$117.15Hold$00.0000.00% ROIAORTArtivion8/22/2025Boost Price Target$43.12$50.00Buy$00.0000.00% ROIMDTMedtronic8/14/2025Reiterated Rating$92.04Hold$00.0000.00% ROILUCDLucid Diagnostics8/13/2025Reiterated Rating$0.99$3.00Buy$0.0000.00% ROIAORTArtivion8/8/2025Boost Price Target$32.78$45.00Buy$00.0000.00% ROIENOVEnovis8/7/2025Lower Price Target$28.45$49.00Buy$00.0000.00% ROIHAEHaemonetics8/7/2025Reiterated Rating$56.94$68.00Buy$00.0000.00% ROISYKStryker8/1/2025Boost Price Target$393.37$448.00Buy$000.0000.00% ROIINMDInMode7/30/2025Reiterated Rating$14.09Hold$00.0000.00% ROIATRCAtriCure7/30/2025Boost Price Target$31.73$45.00Buy$00.0000.00% ROINEONeoGenomics7/29/2025Lower Price Target$5.25$8.00Buy$00.0000.00% ROIMMSIMerit Medical Systems7/18/2025Reiterated Rating$84.54$108.00Buy$00.0000.00% ROILUCDLucid Diagnostics7/16/2025Reiterated Rating$1.19$3.00Buy$0.0000.00% ROIMMSIMerit Medical Systems7/8/2025Reiterated Rating$91.12$108.00Buy$00.0000.00% ROITMDXTransMedics Group6/17/2025Reiterated Rating$141.96Hold$00.0000.00% ROIESTAEstablishment Labs6/13/2025Reiterated Rating$37.12$48.00Buy$00.0000.00% ROICNMDCONMED6/12/2025Downgrade$57.02$61.00Hold$00.0000.00% ROIMDTMedtronic6/6/2025Reiterated Rating$86.92Hold$00.0000.00% ROITMDXTransMedics Group6/3/2025Reiterated Rating$123.94Hold$00.0000.00% ROIBSXBoston Scientific5/28/2025Reiterated Rating$105.21$115.00Buy$00.0000.00% ROIHOLXHologic5/27/2025Reiterated Rating$62.14Hold$0.0000.00% ROIINGNInogen5/22/2025Upgrade$5.96$12.00Moderate Buy$0.0000.00% ROIMDTMedtronic5/19/2025Reiterated Rating$86.41Hold$00.0000.00% ROIMMSIMerit Medical Systems5/15/2025Boost Price Target$97.77$108.00Buy$00.0000.00% ROIESTAEstablishment Labs5/14/2025Upgrade$34.96$48.00Buy$00.0000.00% ROILUCDLucid Diagnostics5/14/2025Reiterated Rating$1.24$3.00Buy$0.0000.00% ROILIVNLivaNova5/13/2025Reiterated Rating$45.23$64.00Buy$00.0000.00% ROIENOVEnovis5/9/2025Lower Price Target$33.11$57.00Buy$00.0000.00% ROIKIDSOrthoPediatrics5/8/2025Reiterated Rating$22.21$42.00Buy$00.0000.00% ROIVCYTVeracyte5/8/2025Lower Price Target$30.80$41.00Buy$00.0000.00% ROIHAEHaemonetics5/8/2025Lower Price Target$68.55$84.00Buy$00.0000.00% ROIAORTArtivion5/6/2025Reiterated Rating$23.69$32.00Buy$00.0000.00% ROIHOLXHologic5/2/2025Reiterated Rating$57.28Hold$0.0000.00% ROICNMDCONMED5/1/2025Lower Price Target$48.91$61.00Buy$00.0000.00% ROIATRCAtriCure4/30/2025Lower Price Target$34.65$44.00Buy$00.0000.00% ROISRDXSurmodics4/30/2025Reiterated Rating$27.77Hold$0.0000.00% ROINEONeoGenomics4/29/2025Lower Price Target$6.69$8.50Buy$0.0000.00% ROIINMDInMode4/28/2025Reiterated Rating$14.32Hold$00.0000.00% ROIMMSIMerit Medical Systems4/25/2025Lower Price Target$94.67$100.00Buy$00.0000.00% ROIBSXBoston Scientific4/24/2025Boost Price Target$101.56$115.00Buy$00.0000.00% ROITMDXTransMedics Group4/23/2025Reiterated Rating$91.21Hold$000.0000.00% ROIBSXBoston Scientific4/16/2025Upgrade$94.19$113.00Buy$00.0000.00% ROIESTAEstablishment Labs4/14/2025Initiated Coverage$30.34Hold$00.0000.00% ROILUCDLucid Diagnostics4/11/2025Reiterated Rating$1.25$3.00Buy$0.0000.00% ROIMASIMasimo4/10/2025Reiterated Rating$164.57Hold$000.0000.00% ROIPSNLPersonalis4/10/2025Reiterated Rating$3.38$7.00Buy$0.0000.00% ROIINGNInogen4/9/2025Reiterated Rating$6.59Hold$0.0000.00% ROIMMSIMerit Medical Systems4/9/2025Reiterated Rating$88.48$116.00Buy$00.0000.00% ROIKIDSOrthoPediatrics4/9/2025Reiterated Rating$21.77$42.00Buy$00.0000.00% ROIA new kind of civil war is coming after election day? (Ad)Across America, AI-driven backlash is fueling protests, lawsuits, and moratoria that could reshape the political and investment landscape. Whitney Tilson believes tensions may come to a head at midnight on November 4th, the day after the midterm elections, with major implications for your portfolio.Read Whitney Tilson's free analysis on what could happen next.ENOVEnovis4/9/2025Reiterated Rating$30.60$64.00Buy$00.0000.00% ROIINMDInMode4/9/2025Reiterated Rating$14.48Hold$00.0000.00% ROIICUIICU Medical4/8/2025Reiterated Rating$142.25Hold$000.0000.00% ROISTESTERIS4/7/2025Reiterated Rating$212.69Hold$000.0000.00% ROIENOVEnovis4/2/2025Reiterated Rating$35.88$64.00Buy$00.0000.00% ROIATRCAtriCure3/27/2025Reiterated Rating$33.62$51.00Buy$00.0000.00% ROITMDXTransMedics Group3/26/2025Reiterated Rating$70.79Hold$000.0000.00% ROILUCDLucid Diagnostics3/24/2025Boost Price Target$1.54$3.00Buy$0.0000.00% ROIATRCAtriCure3/21/2025Reiterated Rating$34.82$51.00Buy$00.0000.00% ROISYKStryker3/21/2025Reiterated Rating$373.69$442.00Buy$000.0000.00% ROIHAEHaemonetics3/18/2025Lower Price Target$64.84$104.00Buy$00.0000.00% ROILIVNLivaNova3/17/2025Reiterated Rating$39.24$64.00Buy$00.0000.00% ROITFXTeleflex3/12/2025Reiterated Rating$139.25Hold$000.0000.00% ROIKIDSOrthoPediatrics3/5/2025Reiterated Rating$22.89$42.00Buy$00.0000.00% ROIBSXBoston Scientific3/3/2025Reiterated Rating$104.59Hold$00.0000.00% ROIPSNLPersonalis2/28/2025Lower Price Target$4.24$7.00Buy$0.0000.00% ROIENOVEnovis2/27/2025Lower Price Target$40.03$64.00Buy$00.0000.00% ROIINGNInogen2/26/2025Reiterated Rating$9.52Hold$0.0000.00% ROIMMSIMerit Medical Systems2/26/2025Lower Price Target$102.05$116.00Buy$00.0000.00% ROIMASIMasimo2/26/2025Reiterated Rating$169.54Hold$000.0000.00% ROILIVNLivaNova2/26/2025Lower Price Target$41.70$64.00Buy$00.0000.00% ROIAORTArtivion2/25/2025Lower Price Target$27.90$32.00Buy$00.0000.00% ROIVCYTVeracyte2/25/2025Reiterated Rating$39.36$51.00Buy$00.0000.00% ROIPENPenumbra2/19/2025Reiterated Rating$270.99Hold$000.0000.00% ROIMDTMedtronic2/19/2025Reiterated Rating$86.05Hold$00.0000.00% ROINEONeoGenomics2/19/2025Lower Price Target$12.40$18.00Buy$00.0000.00% ROIATRCAtriCure2/13/2025Reiterated Rating$42.36$51.00Buy$00.0000.00% ROIMDTMedtronic2/12/2025Reiterated Rating$91.18Hold$000.0000.00% ROIZBHZimmer Biomet2/7/2025Reiterated Rating$102.84Hold$00.0000.00% ROIHAEHaemonetics2/7/2025Lower Price Target$62.95$108.00Buy$00.0000.00% ROICNMDCONMED2/6/2025Lower Price Target$74.35$91.00Buy$00.0000.00% ROIBSXBoston Scientific2/6/2025Reiterated Rating$104.95Hold$00.0000.00% ROITMDXTransMedics Group2/5/2025Reiterated Rating$72.14Hold$000.0000.00% ROIINMDInMode2/4/2025Reiterated Rating$16.80Hold$00.0000.00% ROIHOLXHologic2/3/2025Downgrade$72.14$90.00Hold$00.0000.00% ROIRMDResMed1/31/2025Reiterated Rating$257.63Hold$000.0000.00% ROIINGNInogen1/30/2025Reiterated Rating$12.53Hold$0.0000.00% ROISRDXSurmodics1/30/2025Reiterated Rating$35.61Hold$0.0000.00% ROIVCYTVeracyte1/29/2025Boost Price Target$43.67$51.00Buy$00.0000.00% ROISYKStryker1/29/2025Reiterated Rating$394.92$442.00Buy$000.0000.00% ROIMMSIMerit Medical Systems1/29/2025Boost Price Target$109.03$122.00Buy$00.0000.00% ROIZBHZimmer Biomet1/29/2025Reiterated Rating$112.06Hold$00.0000.00% ROIFNAParagon 281/29/2025Reiterated Rating$13.03$13.00Hold$0.0000.00% ROILIVNLivaNova1/28/2025Reiterated Rating$49.53$75.00Buy$00.0000.00% ROIAORTArtivion1/28/2025Reiterated Rating$30.82$34.00Buy$00.0000.00% ROIATRCAtriCure1/22/2025Boost Price Target$39.63$51.00Buy$00.0000.00% ROIMASIMasimo1/22/2025Reiterated Rating$176.07Hold$000.0000.00% ROIMASIMasimo1/16/2025Reiterated Rating$170.69Hold$000.0000.00% ROIKIDSOrthoPediatrics1/14/2025Reiterated Rating$25.00$42.00Buy$00.0000.00% ROIINGNInogen1/14/2025Reiterated Rating$10.33Hold$0.0000.00% ROII don't write about politics. Until today. (Ad)Polls have favored a House flip all summer, and forecasters now expect Washington to change hands in November. The question on everyone's mind: what happens to my savings if that happens? The right time to prepare is before the rules change, not after. Whatever happens on Election Day, those who prepare now will be ready either way.See where to start preparing your retirement before NovemberMMSIMerit Medical Systems1/14/2025Reiterated Rating$95.64$109.00Buy$00.0000.00% ROIHOLXHologic1/13/2025Reiterated Rating$71.70$90.00Buy$00.0000.00% ROIFNAParagon 281/13/2025Reiterated Rating$10.80$13.00Buy$0.0000.00% ROIATRCAtriCure1/13/2025Reiterated Rating$33.18$40.00Buy$00.0000.00% ROINEONeoGenomics1/10/2025Reiterated Rating$14.93$19.00Buy$00.0000.00% ROITMDXTransMedics Group12/11/2024Reiterated Rating$68.99Hold$000.0000.00% ROITMDXTransMedics Group12/3/2024Reiterated Rating$85.14Hold$000.0000.00% ROIHAEHaemonetics12/3/2024Reiterated Rating$85.33$112.00Buy$00.0000.00% ROIBSXBoston Scientific11/27/2024Reiterated Rating$90.19Hold$000.0000.00% ROITMDXTransMedics Group11/22/2024Reiterated Rating$79.34$109.00Hold$000.0000.00% ROIBSXBoston Scientific11/18/2024Reiterated Rating$90.81Hold$000.0000.00% ROIHAEHaemonetics11/15/2024Reiterated Rating$89.20$112.00Buy$00.0000.00% ROIICUIICU Medical11/13/2024Reiterated Rating$178.01Hold$000.0000.00% ROISRDXSurmodics11/7/2024Reiterated Rating$38.49Hold$00.0000.00% ROIBSXBoston Scientific10/31/2024Reiterated Rating$84.02Hold$000.0000.00% ROISYKStryker10/30/2024Boost Price Target$359.25$409.00Buy$000.0000.00% ROITMDXTransMedics Group10/29/2024Lower Price Target$126.24$109.00Buy$000.0000.00% ROIRMDResMed10/25/2024Reiterated Rating$239.05Hold$000.0000.00% ROIBSXBoston Scientific10/24/2024Reiterated Rating$87.45Hold$000.0000.00% ROIBSXBoston Scientific10/18/2024Downgrade$86.43$86.00Hold$00.0000.00% ROIICUIICU Medical10/10/2024Reiterated Rating$177.70Hold$000.0000.00% ROIRMDResMed10/1/2024Reiterated Rating$244.13Hold$000.0000.00% ROIRMDResMed9/18/2024Reiterated Rating$250.88Hold$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageJefferies Financial GroupBMO Capital MarketsWall Street ZenUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.The Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank Aktiengesellschaft Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.